Diversity and evolution of the small multidrug resistance protein family

Denice C Bay1, Raymond J Turner

  • 1Department of Biological Sciences, University of Calgary, Calgary, Alberta, T2N 1N4, Canada. dbay@ucalgary.ca

Abstract

Insights

Small multidrug resistance (SMR) proteins may have evolved from ancestral transporters. This study reveals their evolutionary links to larger superfamilies and suggests a recent origin for PSMR sequences via gene duplication.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Bioinformatics

Background:

  • Small multidrug resistance (SMR) proteins are integral membrane proteins conferring bacterial resistance to antiseptics and quaternary ammonium compounds (QAC).
  • Their structure suggests they may be ancestral to larger transporter superfamilies like MFS and DMT.
  • Previous studies have explored SMR origins, but a comprehensive analysis was needed.

Purpose of the Study:

  • To investigate the evolutionary association between SMR proteins and larger multidrug transporters.
  • To expand upon existing knowledge of the SMR protein family's origins and evolution.

Main Methods:

  • Extensive bioinformatics analysis of over 300 SMR sequences from Bacteria.
  • Phylogenetic analysis and protein alignments for SMR subclass annotation (SMP, SUG, PSMR).
  • Synonymous to non-synonymous substitution rate analysis (Syn-SCAN) to determine selection pressure.

Main Results:

  • Identified unique SMR subclass distributions across bacterial and archaeal taxa.
  • SUG and SMP subclasses face moderate selection pressure, while PSMR sequences experience lower pressure with rapid divergence in one pair.
  • Common transmembrane domains between SMR subclasses and other transporters (BAT, DMT, MFS) support SMR's role in multidrug transport evolution.

Conclusions:

  • Paired small multidrug resistance (PSMR) sequences recently originated from SUG and SMP clades via gene duplication.
  • SMR proteins appear to be evolving towards specialized metabolite transport functions.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...